The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Optilast, 0.5 mg/ml Eye Drops, solution

Mylan IRE Healthcare LimitedPA2010/047/001

Main Information

Trade NameOptilast, 0.5 mg/ml Eye Drops, solution
Active SubstancesAzelastine hydrochloride
Dosage FormEye drops, solution
Licence HolderMylan IRE Healthcare Limited
Licence NumberPA2010/047/001

Group Information

ATC CodeS01GX Other antiallergics
S01GX07 azelastine


License statusAuthorised
Licence Issued28/08/1998
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back